Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy
NCT05793359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62
Last updated 2023-03-31
Summary
The goal of this interventional study is to compare the effectiveness of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves' orbitopathy. The main questions it aims to answer are:
1. Are the two glucocorticoid regimens similarly effective?
2. Do the two glucocorticoid regimens have similar safety profile? The patients involved are treated with one of the two glucocorticoid regimens. Their ocular status, therapeutic response and quality of life reassessed during the treatment, at its end, and 3 month later.
Conditions
- Graves Ophthalmopathy
Interventions
- DRUG
-
Methylprednisolone
methylprednisolone applied as intravenous infusions or intramuscularly
Sponsors & Collaborators
-
Medical University of Sofia
lead OTHER
Principal Investigators
-
Mariya D Stoynova, PhD · Medical University of Sofia: Medicinski universitet-Sofia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-25
- Primary Completion
- 2021-02-25
- Completion
- 2021-02-25
Countries
- Bulgaria
Study Locations
More Related Trials
-
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01110499 ·Status: COMPLETED ·Phase: PHASE2
-
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
NCT00449956 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
NCT02829996 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
NCT02531152 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT03293992 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution
NCT01001195 ·Status: COMPLETED ·Phase: PHASE2
-
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination
NCT00941096 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
NCT02780115 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
NCT00809848 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
NCT00329095 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
NCT01520116 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Travoprost/Timolol BAC-free
NCT00760539 ·Status: COMPLETED ·Phase: PHASE3
-
Stop Retinal Ganglion Cell Dysfunction Study
NCT02390284 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Equivalence Study of Dorzolamide 2% Eye Drops Solution
NCT00878917 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
NCT03131726 ·Status: RECRUITING ·Phase: PHASE3
-
Sirolimus in Graves' Orbitopathy
NCT05345119 ·Status: COMPLETED
-
A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
NCT01284309 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension
NCT02507687 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
NCT06984627 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT04445519 ·Status: COMPLETED ·Phase: PHASE3
-
24-hour IOP-lowering Effect of 0.01% Bimatoprost
NCT01271686 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
NCT02247804 ·Status: COMPLETED ·Phase: PHASE3
-
Bimatoprost as a Treatment for Graves' Orbitopathy
NCT03708627 ·Status: RECRUITING ·Phase: EARLY_PHASE1